SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - XERIS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$672,000
+14.9%
274,473
+91.1%
0.01%
+9.1%
Q2 2021$585,000
+735.7%
143,639
+916.4%
0.01%
+1000.0%
Q4 2020$70,000–14,132–0.00%–
 Download
Other shareholders

There were no reported owners of XERIS PHARMACEUTICALS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of XERIS PHARMACEUTICALS INC shareholders